Journal article
Genetic Testing to Guide Warfarin Dosing: Impact of Direct Oral Anticoagulants
Clinical pharmacology and therapeutics, Vol.100(2), pp.128-130
08/01/2016
DOI: 10.1002/cpt.395
PMID: 27178490
Abstract
Despite rapid growth in the use of direct oral anticoagulants (DOACs), warfarin remains a widely prescribed anticoagulant drug. It is likely that the overall use of warfarin will continue to decline, but not completely disappear, as indications for DOACs expand. This changing anticoagulation landscape, along with the likelihood that personalized genomic information will become increasingly available, has several implications for the future of warfarin dosing strategies.
Details
- Title: Subtitle
- Genetic Testing to Guide Warfarin Dosing: Impact of Direct Oral Anticoagulants
- Creators
- S. R. Lentz - Roy J. and Lucille A. Carver College of Medicine
- Resource Type
- Journal article
- Publication Details
- Clinical pharmacology and therapeutics, Vol.100(2), pp.128-130
- Publisher
- Wiley
- DOI
- 10.1002/cpt.395
- PMID
- 27178490
- ISSN
- 0009-9236
- eISSN
- 1532-6535
- Number of pages
- 4
- Language
- English
- Date published
- 08/01/2016
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984359908702771
Metrics
13 Record Views